What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added ...

Discover the factors behind UnitedHealth's recent stock plunge and what it means for investors. Is UNH still a viable investment or a falling knife?

The company has invoked the murder of an executive last year to complain about coverage in news outlets, on streaming ...

UnitedHealth Group is preparing to report its Q2 2025 earnings, with analysts predicting a drop in earnings per share (EPS) to $5.08. The company’s stock has underperformed significantly over the last ...

Kaskela Law LLC announces that it is investigating UnitedHealth Group Inc. (NYSE: UNH) (“UnitedHealth”) on behalf of the company’s long-term investors. Click here to learn more about this ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda. Prosecutors Question Doctors About UnitedHealth's Medicare Billing Practices ...

Stock futures were little changed Tuesday night as investors monitor the latest tariff updates from President Donald Trump.

Stocks on Wall Street closed broadly lower Monday as the White House stepped up pressure on major trading partners to make ...

Last week, the Trump administration announced that it reached a deal with Vietnam that would allow U.S. goods to enter the ...

UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.

UnitedHealth continued to be the largest US insurer by market capitalization during the second quarter, even as it ...

UnitedHealth Group’s stock closed at $307.56, showing a -5.7% change in the most recent trading session, underperforming ...